These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 28929334

  • 1. Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry.
    Nasu K, Oikawa Y, Habara M, Shirai S, Abe H, Kadotani M, Gotoh R, Hozawa H, Ota H, Suzuki T, Shibata Y, Tanabe M, Nakagawa Y, Serikawa T, Nagasaka S, Takeuchi Y, Fujimoto Y, Tamura H, Kobori Y, Yajima J, Aizawa T, Suzuki T, NO-RECOIL Registries Investigators.
    Cardiovasc Interv Ther; 2018 Oct; 33(4):321-327. PubMed ID: 28929334
    [Abstract] [Full Text] [Related]

  • 2. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
    Waksman R, Piegari GN, Kabour A, Cannon L, Wang J, Adams G, Solankhi N, Smeglin A, Kereiakes DJ, Leiboff R, Spad MA, Torguson R, Chandra N, Bastian R, DeGroot J, Kayo MW, Stoll HP, Garcia-Garcia HM.
    Cardiovasc Revasc Med; 2017 Oct; 18(7):475-481. PubMed ID: 28923692
    [Abstract] [Full Text] [Related]

  • 3. Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.
    Muramatsu T, Ozaki Y, Nanasato M, Ishikawa M, Nagasaka R, Ohota M, Hashimoto Y, Yoshiki Y, Takatsu H, Ito K, Kamiya H, Yoshida Y, Murohara T, Izawa H, MISTIC-1 Investigators.
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009314. PubMed ID: 33106049
    [Abstract] [Full Text] [Related]

  • 4. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions.
    Cho S, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Contemp Clin Trials; 2015 Jan; 40():90-4. PubMed ID: 25433202
    [Abstract] [Full Text] [Related]

  • 5. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW, ILUMIEN III: OPTIMIZE PCI Investigators.
    Lancet; 2016 Nov 26; 388(10060):2618-2628. PubMed ID: 27806900
    [Abstract] [Full Text] [Related]

  • 6. Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study.
    Kim BK, Shin DH, Hong MK, Park HS, Rha SW, Mintz GS, Kim JS, Kim JS, Lee SJ, Kim HY, Hong BK, Kang WC, Choi JH, Jang Y, CTO-IVUS Study Investigators.
    Circ Cardiovasc Interv; 2015 Jul 26; 8(7):e002592. PubMed ID: 26156151
    [Abstract] [Full Text] [Related]

  • 7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 26; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents.
    Yoon YW, Shin S, Kim BK, Kim JS, Shin DH, Ko YG, Choi D, Jeon DW, Kwon H, Jang Y, Hong MK, RESET Investigators.
    Am J Cardiol; 2013 Sep 01; 112(5):642-6. PubMed ID: 23711810
    [Abstract] [Full Text] [Related]

  • 9. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M.
    Cardiovasc Ther; 2015 Dec 01; 33(6):360-6. PubMed ID: 26363283
    [Abstract] [Full Text] [Related]

  • 10. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C, EXECUTIVE Trial Investigators.
    JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1012-22. PubMed ID: 24055444
    [Abstract] [Full Text] [Related]

  • 11. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions.
    Chen L, Xu T, Xue XJ, Zhang JJ, Ye F, Tian NL, Chen SL.
    Int J Cardiovasc Imaging; 2018 Nov 01; 34(11):1685-1696. PubMed ID: 29981016
    [Abstract] [Full Text] [Related]

  • 12. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.
    Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A.
    Int J Cardiol; 2018 Mar 01; 254():53-58. PubMed ID: 29407132
    [Abstract] [Full Text] [Related]

  • 13. Can intravascular ultrasound guidance modify the efficacy of drug-eluting stent over bare-metal stent in an aorto-ostial lesion?
    Okabe T, Kawamura A, Maekawa Y, Anzai T, Iwanaga S, Yoshikawa T, Ogawa S.
    Cardiovasc Revasc Med; 2011 Mar 01; 12(2):105-10. PubMed ID: 21421189
    [Abstract] [Full Text] [Related]

  • 14. Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial.
    Lee JY, Park DW, Kim YH, Ahn JM, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Yang TH, Lee BK, Lee NH, Yang JY, Shin WY, Park HS, Kim KS, Hur SH, Lee SY, Park JS, Choi YS, Lee SU, Her SH, Park SJ.
    Circ Cardiovasc Interv; 2014 Jun 01; 7(3):322-9. PubMed ID: 24823426
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
    Raungaard B, Christiansen EH, Bøtker HE, Hansen HS, Ravkilde J, Thuesen L, Aarøe J, Villadsen AB, Terkelsen CJ, Krusell LR, Maeng M, Kristensen SD, Veien KT, Hansen KN, Junker A, Madsen M, Andersen SL, Jensen SE, Jensen LO, SORT OUT VI Investigators.
    JACC Cardiovasc Interv; 2017 Feb 13; 10(3):255-264. PubMed ID: 28109874
    [Abstract] [Full Text] [Related]

  • 16. Two-year results after coronary stenting of small vessels in Japanese population using 2.25-mm diameter sirolimus-eluting stent with bioresorbable polymer: primary and long-term outcomes of CENTURY JSV study.
    Saito S, Ando K, Ito Y, Tobaru T, Yajima J, Kimura T, Kadota K.
    Cardiovasc Interv Ther; 2019 Jan 13; 34(1):25-33. PubMed ID: 29349686
    [Abstract] [Full Text] [Related]

  • 17. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
    Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ.
    J Am Coll Cardiol; 2009 Mar 24; 53(12):1031-9. PubMed ID: 19298915
    [Abstract] [Full Text] [Related]

  • 18. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
    Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, Tian N, Lin S, Lu Q, Wu X, Li Q, Liu Z, Chen Y, Qian X, Wang J, Chai D, Chen C, Li X, Gogas BD, Pan T, Shan S, Ye F, Chen SL.
    J Am Coll Cardiol; 2018 Dec 18; 72(24):3126-3137. PubMed ID: 30261237
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of Frequency Domain Optical Coherence Tomography Compared with Intravascular Ultrasound as a Guidance for Percutaneous Coronary Intervention.
    Kim IC, Yoon HJ, Shin ES, Kim MS, Park J, Cho YK, Park HS, Kim H, Nam CW, Han SW, Kim YN, Kim KB, Hur SH.
    J Interv Cardiol; 2016 Apr 18; 29(2):216-24. PubMed ID: 26927366
    [Abstract] [Full Text] [Related]

  • 20. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y, Attizzani GF, Tahara S, Naganuma T, Takagi K, Yabushita H, Wang W, Tanaka K, Matsumoto T, Kawamoto H, Yamada Y, Amano S, Watanabe Y, Warisawa T, Sato T, Mitomo S, Kurita N, Ishiguro H, Hozawa K, Tsukahara T, Motosuke M, Bezerra HG, Nakamura S, Nakamura S.
    Int J Cardiol; 2017 Mar 01; 230():284-292. PubMed ID: 28065691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.